Background and objective: There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who care for multipathological patients. Materials and methods: The "deprescription questionnaire...
-
February 13, 2024 (v1)PublicationUploaded on: February 16, 2024
-
February 27, 2024 (v1)Publication
Antecedentes y objetivo: En 2017 se desarrolló un cuestionario en italiano que tenía como objetivo deter minar las percepciones de los clínicos ante la desprescripción en población de edad avanzada. El objetivo fue traducir y adaptar transculturalmente al espanol ˜ este cuestionario de desprescripción. Métodos: Traducción directa y...
Uploaded on: March 3, 2024 -
February 13, 2024 (v1)Publication
Background and Objectives: Potentially inappropriate medication refers to the prescription of drugs whose risks outweigh the benefits. There are different pharmacotherapeutic optimization strategies to detect and avoid potentially inappropriate medications (PIMs), namely deprescription. The List of Evidence-Based Deprescribing for Chronic...
Uploaded on: February 16, 2024 -
February 26, 2024 (v1)Publication
Objective LESS-CHRON (List of Evidence-Based Deprescribing for Chronic Patients) and STOPPFrail (Screening Tool of Older Persons' Prescriptions in Frail adults with limited life expectancy) are criterion-based deprescribing tools. This study aimed to identify the prevalence of potentially inappropriate medications (PIMs) with these tools in an...
Uploaded on: February 28, 2024 -
February 29, 2024 (v1)Publication
Background: Anticholinergic and sedative drugs are associated with adverse events such as cognitive and functional impairment in elderly. The Drug Burden Index (DBI) is a measure of an individual's total exposure to anticholinergic and sedative drugs. Objetive: The study aimed to evaluate the association between the total DBI and cognitive and...
Uploaded on: March 3, 2024